International Congress Munich 2014


The rise in non-tuberculous mycobacteria (NTM) pulmonary diseases

Symposium
Chairs: W. Hoefsloot (Nijmegen, Netherlands), D. Wagner (Freiburg, Germany)
Aims: During this symposium, the audience will:
- Obtain up-to-date information on the risk factors and handling of patients with COPD and NTM pulmonary disease (PD);
- Understand problems in decision making in patients with cystic fibrosis (CF) and NTM-PD;
- Learn about the care of patients with non-CF bronchiectasis and the options gained by using a research registry; and,
- Learn about caveats of and have a look beyond current treatment options.
Risk factors of pulmonary NTM disease in COPD: how bad are glucocorticoids?
C. Andrejak (Amiens, France)
WebcastSlide presentationMultimedia files
WebcastSlide presentationMultimedia files